DNM3 attenuates hepatocellular carcinoma growth by activating P53

Medical Science Monitor

Volumn 22, Issue , 2016, Pages 197-205

  Zhang, Zhengdong ^a,b   Chen, Chun ^a   Guo, Weike ^b   Zheng, Shengbao ^b   Sun, Zhenghua ^b   Geng, Xiaoping ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Tongling Municipal Hospital   (China)

Author keywords

Carcinoma; Cell proliferation; Dynamin III; Genes; Hepatocellular; P53

Indexed keywords

DYNAMIN III; PROTEIN P53; MESSENGER RNA;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; AGED; CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE; TUMOR STEM CELL ASSAY;

AGED; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DYNAMIN III; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, MESSENGER; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84955445761     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.896545     Document Type: Article

References (23)

1. Jemal A, Bray F, Center MM et al: Global cancer statistics. Cancer J Clin, 2011; 61(2): 69-90.
2. Inokawa Y, Nomoto S, Hishida M et al: Dynamin 3: A new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis. Onco Targets Ther, 2013; 6: 1417-24.
3. Shen J, Wang S, Zhang YJ et al: Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology, 2012; 55(6): 1799-808.
4. Jiang D, Xu C, Li Z et al: Protective action of hepatocyte growth factor on transforming growth factor beta-1-induced alpha-smooth muscle actin and extracellular matrix in cultured human peritoneal fibroblasts. Med Sci Monit, 2010; 16(8): BR250-54.
5. Shao Z, Ji W, Liu A et al: TSG101 silencing suppresses hepatocellular carcinoma cell growth by inducing cell cycle arrest and autophagic cell death. Med Sci Monit, 2015; 21: 3371-79.
6. Wang BF, Lin S, Bai MH et al: Effects of SSd combined with radiation on inhibiting SMMC-7721 hepatoma cell growth. Med Sci Monit, 2014; 20: 1340-44.
7. Cao S, Yao J, Shah V: The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function. J Biol Chem, 2003; 278(8): 5894-901.
8. Hyndman KA, Musall JB, Xue J, Pollock JS: Dynamin activates NO production in rat renal inner medullary collecting ducts via protein-protein interaction with NOS1. Am J Physio Renal Physiol, 2011; 301(1): F118-24.
9. Jenkins DC, Charles IG, Thomsen LL et al: Roles of nitric-oxide in tumor- growth. Proc Natl Acad Sci USA, 1995; 92(10): 4392-96.
10. Le X, Wei D, Huang S et al: Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors. Proc Natl Acad Sci USA, 2005; 102(24): 8758-63.
11. Yang YC, Xiao DW, Liu H et al: Mechanism of simvastatin-induced K562 cell apoptosis. Pharmacology, 2009; 84(4): 191-95.
12. Isik A, Peker K, Firat D et al: Importance of metastatic lymph node ratio in non-metastatic, lymph node-invaded colon cancer: A clinical trial. Med Sci Monit, 2014; 20: 1369-75.
13. Isik A, Okan I, Firat D et al: A new prognostic strategy for gastric carcinoma: Albumin level and metastatic lymph node ratio. Minerva Chir, 2014; 69(3): 147-53.
14. Rakshit S, Bagchi J, Mandal L et al: N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl(+) cells by endothelial nitric oxide synthase- mediated production of nitric oxide. Apoptosis, 2009; 14(3): 298-308.
15. Notas G, Nifli AP, Kampa M et al: Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim Biophys Acta, 2006; 1760(11): 1657-66.
16. Lala PK, Chakraborty C: Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol, 2001; 2(3): 149-56.
17. Soliman MK, Mazzio E, Soliman KF: Levodopa modulating effects of inducible nitric oxide synthase and reactive oxygen species in glioma cells. Life Sci, 2002; 72(2): 185-98.
18. Lim S, Hung AC, Porter AG: Focused PCR screen reveals p53 dependence of nitric oxide-induced apoptosis and up-regulation of maspin and plasminogen activator inhibitor-1 in tumor cells. Mol Cancer Res, 2009; 7(1): 55-66.
19. Gorospe M, Wang X, Holbrook NJ: Functional role of p21 during the cellular response to stress. Gene Expr, 1999; 7(4-6): 377-85.
20. Amaral JD, Xavier JM, Steer CJ, Rodrigues CM: The role of p53 in apoptosis. Discov Med, 2010; 9(45): 145-52.
21. Gardner PR, Gardner AM, Brashear WT et al: Hemoglobins dioxygenate nitric oxide with high fidelity. J Inorg Biochem, 2006; 100(4): 542-50.
22. Vicetti Miguel RD, Cherpes TL, Watson LJ, McKenna KC: CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination. J Immunol, 2010; 185(11): 6706-18.
23. Jurasz P, Sawicki G, Duszyk M et al: Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: Regulation by nitric oxide. Cancer Res, 2001; 61(1): 376-82.